Hermogenes Battad, MD
Pulmonary Disease · Gallatin, TNNPI 1508838400
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $284 of the $316 with a category attached, or 89.7%. It is spread thinly across 9 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $247 and has fallen 88.6% since, to $28 in 2023. That places this record below the midpoint for pulmonary disease clinicians in TN, where the typical reported total is $3,628.
Across 17 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$62
- Sunovion Pharmaceuticals Inc.$55
- Electromed, Inc.$53
- Insmed, Inc.$48
- Boehringer Ingelheim$33
- Johnson & Johnson$25
- plus $41 from 3 others
What the payments were for
- Food & beverage$28490%
- Education$3210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 3 | $62 |
| Sunovion Pharmaceuticals Inc. | 5 | $55 |
| Electromed, Inc. | 1 | $53 |
| Insmed, Inc. | 3 | $48 |
| Boehringer Ingelheim | 1 | $33 |
| Johnson & Johnson | 1 | $25 |
| Boston Scientific | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Ceribell, Inc. | 1 | $12 |
How this compares
$316 in reported general payments places this provider in the 20th percentile of 339 pulmonary disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $11,630 |
| Bumetanide | 20 | $757 |
| Cefdinir | 50 | $534 |
| Potassium Chloride | 48 | $329 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $315 |
| Pantoprazole Sodium | 35 | $283 |
| Doxycycline Hyclate | 47 | $241 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $169 |
| Atorvastatin Calcium | 20 | $144 |
| Azithromycin | 36 | $135 |
| Prednisone | 79 | $101 |
| Losartan Potassium | 18 | $82 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $66 |
| Metoprolol Tartrate | 20 | $58 |
| Furosemide | 34 | $56 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Gallatin
- Marc HofmannGallatin$49K
- Lisa LancasterNashville$519K
- Krishnendu BhadraChattanooga$494K
- Aaron MilstoneFranklin$482K
- Otis RickmanNashville$392K
- Michael CzarneckiChattanooga$348K
- Susan GarwoodNashville$343K
- Girendra HoskereBristol$285K
- Carlos BaleeiroChattanooga$265K
- Joao DeandradeNashville$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.